81/100B547.03
USD
4.03
(0.74%)
Pre Open·549.72USD+2.69(+0.49%)
Last updated: · Delayed 15 min
Vertex Pharmaceuticals current ratioWhat is the current ratio? The current ratio is current assets divided by current liabilities: whether what a company will turn into cash within a year covers what it owes within a year.
Vertex Pharmaceuticals's current ratio is 2.34: current assets of 11.69B USD against current liabilities of 5.00B USD due within a year.
- Today
- 2.34
- Average, 5 years
- 3.49
- Low, 5 years
- 2.34
- High, 5 years
- 4.83
Current ratio = current assets ÷ current liabilities = 11.69B ÷ 5.00B = 2.34
Current ratio
Total current assets
Total current liabilities
Current assets over current liabilities at each quarter end: above 1, what falls due within a year is covered by what turns into cash within a year.
Current ratio by year and by quarter
| Fiscal year | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Today | 2.34 | 11.69B | 5.00B | |
| FY2025 | 31 Dec 2025 | 2.90 | 11.20B | 3.86B |
| FY2024 | 31 Dec 2024 | 2.69 | 9.60B | 3.56B |
| FY2023 | 31 Dec 2023 | 3.99 | 14.14B | 3.55B |
| FY2022 | 31 Dec 2022 | 4.83 | 13.23B | 2.74B |
| FY2021 | 31 Dec 2021 | 4.46 | 9.56B | 2.14B |
| FY2020 | 31 Dec 2020 | 4.33 | 8.13B | 1.88B |
| FY2019 | 31 Dec 2019 | 3.61 | 4.82B | 1.33B |
| FY2018 | 31 Dec 2018 | 3.43 | 3.84B | 1.12B |
| FY2017 | 31 Dec 2017 | 3.28 | 2.65B | 807.26M |
| FY2016 | 31 Dec 2016 | 2.31 | 1.83B | 792.54M |
| FY2015 | 31 Dec 2015 | 2.78 | 1.41B | 506.17M |
| FY2014 | 31 Dec 2014 | 4.20 | 1.55B | 368.25M |
| FY2013 | 31 Dec 2013 | 3.99 | 1.59B | 397.83M |
| FY2012 | 31 Dec 2012 | 3.67 | 1.59B | 432.62M |
| FY2011 | 31 Dec 2011 | 3.39 | 1.33B | 392.35M |
| FY2010 | 31 Dec 2010 | 2.23 | 1.06B | 474.78M |
| FY2009 | 31 Dec 2009 | 4.59 | 1.31B | 284.88M |
| FY2008 | 31 Dec 2008 | 4.01 | 867.58M | 216.56M |
| FY2007 | 31 Dec 2007 | 2.49 | 496.85M | 199.28M |
| FY2006 | 31 Dec 2006 | 3.07 | 771.41M | 251.01M |
| FY2005 | 31 Dec 2005 | 3.84 | 385.06M | 100.24M |
| FY2004 | 31 Dec 2004 | 2.61 | 400.64M | 153.75M |
| FY2003 | 31 Dec 2003 | 4.27 | 593.81M | 139.07M |
| FY2002 | 31 Dec 2002 | 10.16 | 656.57M | 64.60M |
| FY2001 | 31 Dec 2001 | 8.48 | 776.09M | 91.55M |
| FY2000 | 31 Dec 2000 | 7.20 | 503.29M | 69.86M |
| FY1999 | 31 Dec 1999 | 10.54 | 195.20M | 18.52M |
| FY1998 | 31 Dec 1998 | 18.98 | 248.70M | 13.10M |
| FY1997 | 31 Dec 1997 | 20.55 | 281.60M | 13.70M |
| FY1996 | 31 Dec 1996 | 18.62 | 132.20M | 7.10M |
| FY1995 | 31 Dec 1995 | 9.99 | 87.90M | 8.80M |
| FY1994 | 31 Dec 1994 | 17.82 | 106.90M | 6.00M |
| FY1993 | 31 Dec 1993 | 7.27 | 53.10M | 7.30M |
| FY1992 | 31 Dec 1992 | 11.28 | 44.00M | 3.90M |
| FY1991 | 31 Dec 1991 | 19.15 | 51.70M | 2.70M |
| FY1990 | 31 Dec 1990 | 2.88 | 4.60M | 1.60M |
| Quarter | Period ending | Current ratio | Total current assets | Total current liabilities |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 2.34 | 11.69B | 5.00B |
| Q2 FY2026 | 30 Jun 2026 | 3.19 | 12.54B | 3.94B |
| Q1 FY2026 | 31 Mar 2026 | 3.02 | 11.73B | 3.88B |
| Q4 FY2025 | 31 Dec 2025 | 2.90 | 11.20B | 3.86B |
| Q3 FY2025 | 30 Sept 2025 | 2.36 | 10.57B | 4.48B |
| Q2 FY2025 | 30 Jun 2025 | 2.52 | 10.43B | 4.14B |
| Q1 FY2025 | 31 Mar 2025 | 2.65 | 10.01B | 3.78B |
| Q4 FY2024 | 31 Dec 2024 | 2.69 | 9.60B | 3.56B |
| Q3 FY2024 | 30 Sept 2024 | 2.47 | 9.80B | 3.97B |
| Q2 FY2024 | 30 Jun 2024 | 2.52 | 8.94B | 3.55B |
| Q1 FY2024 | 31 Mar 2024 | 3.50 | 13.29B | 3.80B |
| Q4 FY2023 | 31 Dec 2023 | 3.99 | 14.14B | 3.55B |
| Q3 FY2023 | 30 Sept 2023 | 4.08 | 14.70B | 3.60B |
| Q2 FY2023 | 30 Jun 2023 | 4.14 | 13.87B | 3.35B |
| Q1 FY2023 | 31 Mar 2023 | 4.28 | 12.97B | 3.03B |
| Q4 FY2022 | 31 Dec 2022 | 4.83 | 13.23B | 2.74B |
| Q3 FY2022 | 30 Sept 2022 | 4.70 | 12.27B | 2.61B |
| Q2 FY2022 | 30 Jun 2022 | 4.50 | 11.50B | 2.56B |
| Q1 FY2022 | 31 Mar 2022 | 4.75 | 10.36B | 2.18B |
| Q4 FY2021 | 31 Dec 2021 | 4.46 | 9.56B | 2.14B |
| Q3 FY2021 | 30 Sept 2021 | 4.62 | 8.85B | 1.91B |
| Q2 FY2021 | 30 Jun 2021 | 4.61 | 8.46B | 1.84B |
| Q1 FY2021 | 31 Mar 2021 | 4.39 | 8.54B | 1.94B |
| Q4 FY2020 | 31 Dec 2020 | 4.33 | 8.13B | 1.88B |
| Q3 FY2020 | 30 Sept 2020 | 3.72 | 7.46B | 2.00B |
| Q2 FY2020 | 30 Jun 2020 | 3.72 | 6.69B | 1.80B |
| Q1 FY2020 | 31 Mar 2020 | 3.54 | 5.45B | 1.54B |
| Q4 FY2019 | 31 Dec 2019 | 3.61 | 4.82B | 1.33B |
| Q3 FY2019 | 30 Sept 2019 | 3.44 | 4.78B | 1.39B |
| Q2 FY2019 | 30 Jun 2019 | 3.74 | 4.71B | 1.26B |
| Q1 FY2019 | 31 Mar 2019 | 3.78 | 4.18B | 1.11B |
| Q4 FY2018 | 31 Dec 2018 | 3.43 | 3.84B | 1.12B |
| Q3 FY2018 | 30 Sept 2018 | 3.71 | 3.69B | 992.51M |
| Q2 FY2018 | 30 Jun 2018 | 3.67 | 3.41B | 927.30M |
| Q1 FY2018 | 31 Mar 2018 | 3.68 | 3.04B | 827.31M |
| Q4 FY2017 | 31 Dec 2017 | 3.28 | 2.65B | 807.26M |
| Q3 FY2017 | 30 Sept 2017 | 3.28 | 2.33B | 710.74M |
| Q2 FY2017 | 30 Jun 2017 | 3.49 | 2.18B | 625.41M |
| Q1 FY2017 | 31 Mar 2017 | 3.82 | 1.87B | 489.80M |
| Q4 FY2016 | 31 Dec 2016 | 2.31 | 1.83B | 792.54M |
| Q3 FY2016 | 30 Sept 2016 | 2.08 | 1.50B | 722.84M |
| Q2 FY2016 | 30 Jun 2016 | 2.33 | 1.45B | 622.86M |
| Q1 FY2016 | 31 Mar 2016 | 2.54 | 1.40B | 552.04M |
| Q4 FY2015 | 31 Dec 2015 | 2.78 | 1.41B | 506.17M |
| Q3 FY2015 | 30 Sept 2015 | 3.63 | 1.36B | 374.96M |
| Q2 FY2015 | 30 Jun 2015 | 3.46 | 1.29B | 373.82M |
| Q1 FY2015 | 31 Mar 2015 | 4.49 | 1.36B | 302.44M |
| Q4 FY2014 | 31 Dec 2014 | 4.20 | 1.55B | 368.25M |
| Q3 FY2014 | 30 Sept 2014 | 4.43 | 1.65B | 372.18M |
| Q2 FY2014 | 30 Jun 2014 | 3.71 | 1.35B | 362.97M |
| Q1 FY2014 | 31 Mar 2014 | 3.83 | 1.43B | 373.50M |
| Q4 FY2013 | 31 Dec 2013 | 3.99 | 1.59B | 397.83M |
| Q3 FY2013 | 30 Sept 2013 | 4.03 | 1.65B | 409.50M |
| Q2 FY2013 | 30 Jun 2013 | 4.50 | 1.72B | 381.65M |
| Q1 FY2013 | 31 Mar 2013 | 3.84 | 1.57B | 407.64M |
| Q4 FY2012 | 31 Dec 2012 | 3.67 | 1.59B | 432.62M |
| Q3 FY2012 | 30 Sept 2012 | 4.02 | 1.63B | 406.73M |
| Q2 FY2012 | 30 Jun 2012 | 4.20 | 1.59B | 379.71M |
| Q1 FY2012 | 31 Mar 2012 | 4.02 | 1.44B | 356.82M |
| Q4 FY2011 | 31 Dec 2011 | 3.39 | 1.33B | 392.35M |
| Q3 FY2011 | 30 Sept 2011 | 2.27 | 1.25B | 548.95M |
| Q2 FY2011 | 30 Jun 2011 | 1.73 | 827.12M | 478.97M |
| Q1 FY2011 | 31 Mar 2011 | 2.10 | 872.97M | 416.20M |
| Q4 FY2010 | 31 Dec 2010 | 2.23 | 1.06B | 474.78M |
| Q3 FY2010 | 30 Sept 2010 | 3.94 | 1.23B | 311.57M |
| Q2 FY2010 | 30 Jun 2010 | 3.44 | 1.00B | 292.38M |
| Q1 FY2010 | 31 Mar 2010 | 5.33 | 1.13B | 211.54M |
| Q4 FY2009 | 31 Dec 2009 | 4.59 | 1.31B | 284.88M |
| Q3 FY2009 | 30 Sept 2009 | 3.95 | 914.07M | 231.37M |
| Q2 FY2009 | 30 Jun 2009 | 4.26 | 782.76M | 183.68M |
| Q1 FY2009 | 31 Mar 2009 | 5.03 | 902.17M | 179.30M |
| Q4 FY2008 | 31 Dec 2008 | 4.01 | 867.58M | 216.56M |
| Q3 FY2008 | 30 Sept 2008 | 5.28 | 953.02M | 180.46M |
| Q2 FY2008 | 30 Jun 2008 | 4.69 | 857.63M | 182.89M |
| Q1 FY2008 | 31 Mar 2008 | 4.52 | 783.94M | 173.32M |
| Q4 FY2007 | 31 Dec 2007 | 2.49 | 496.85M | 199.28M |
| Q3 FY2007 | 30 Sept 2007 | 2.93 | 543.28M | 185.71M |
| Q2 FY2007 | 30 Jun 2007 | 3.14 | 637.66M | 202.90M |
| Q1 FY2007 | 31 Mar 2007 | 4.05 | 706.54M | 174.59M |
| Q4 FY2006 | 31 Dec 2006 | 3.07 | 771.41M | 251.01M |
| Q3 FY2006 | 30 Sept 2006 | 4.60 | 742.70M | 161.46M |
| Q2 FY2006 | 30 Jun 2006 | 4.16 | 452.59M | 108.74M |
| Q1 FY2006 | 31 Mar 2006 | 4.50 | 370.05M | 82.24M |
| Q4 FY2005 | 31 Dec 2005 | 3.84 | 385.06M | 100.24M |
| Q3 FY2005 | 30 Sept 2005 | 3.48 | 424.33M | 121.81M |
| Q2 FY2005 | 30 Jun 2005 | 3.37 | 465.31M | 137.99M |
| Q1 FY2005 | 31 Mar 2005 | 2.36 | 350.03M | 148.17M |
| Q4 FY2004 | 31 Dec 2004 | 2.61 | 400.64M | 153.75M |
| Q3 FY2004 | 30 Sept 2004 | 3.22 | 432.83M | 134.45M |
| Q2 FY2004 | 30 Jun 2004 | 3.45 | 474.22M | 137.45M |
| Q1 FY2004 | 31 Mar 2004 | 4.41 | 533.44M | 120.84M |
| Q4 FY2003 | 31 Dec 2003 | 4.27 | 593.81M | 139.07M |
| Q3 FY2003 | 30 Sept 2003 | 5.09 | 610.28M | 119.83M |
| Q2 FY2003 | 30 Jun 2003 | 7.50 | 649.24M | 86.52M |
| Q1 FY2003 | 31 Mar 2003 | 12.40 | 697.98M | 56.29M |
| Q4 FY2002 | 31 Dec 2002 | 10.16 | 656.57M | 64.60M |
| Q3 FY2002 | 30 Sept 2002 | 11.46 | 673.65M | 58.79M |
| Q2 FY2002 | 30 Jun 2002 | 11.36 | 707.61M | 62.29M |
| Q1 FY2002 | 31 Mar 2002 | 11.04 | 723.78M | 65.55M |
| Q4 FY2001 | 31 Dec 2001 | 8.48 | 776.09M | 91.55M |
| Q3 FY2001 | 30 Sept 2001 | 4.66 | 428.42M | 91.90M |
| Q2 FY2001 | 30 Jun 2001 | 8.51 | 330.47M | 38.85M |
| Q1 FY2001 | 31 Mar 2001 | 10.46 | 333.28M | 31.87M |
| Q4 FY2000 | 31 Dec 2000 | 7.20 | 503.29M | 69.86M |
| Q3 FY2000 | 30 Sept 2000 | 3.61 | 722.19M | 199.84M |
| Q2 FY2000 | 30 Jun 2000 | 15.68 | 385.52M | 24.59M |
| Q1 FY2000 | 31 Mar 2000 | 22.06 | 353.75M | 16.04M |
| Q4 FY1999 | 31 Dec 1999 | 10.54 | 195.20M | 18.52M |
| Q3 FY1999 | 30 Sept 1999 | 14.82 | 194.10M | 13.10M |
| Q2 FY1999 | 30 Jun 1999 | 14.88 | 211.30M | 14.20M |
| Q1 FY1999 | 31 Mar 1999 | 16.43 | 226.70M | 13.80M |
| Q4 FY1998 | 31 Dec 1998 | 18.98 | 248.70M | 13.10M |
| Q3 FY1998 | 30 Sept 1998 | 23.29 | 260.90M | 11.20M |
| Q2 FY1998 | 30 Jun 1998 | 29.64 | 257.90M | 8.70M |
| Q1 FY1998 | 31 Mar 1998 | 30.75 | 267.50M | 8.70M |
| Q4 FY1997 | 31 Dec 1997 | 20.55 | 281.60M | 13.70M |
| Q3 FY1997 | 30 Sept 1997 | 24.19 | 285.50M | 11.80M |
| Q2 FY1997 | 30 Jun 1997 | 30.95 | 287.80M | 9.30M |
| Q1 FY1997 | 31 Mar 1997 | 30.42 | 276.80M | 9.10M |
| Q4 FY1996 | 31 Dec 1996 | 18.62 | 132.20M | 7.10M |
| Q3 FY1996 | 30 Sept 1996 | 24.52 | 132.40M | 5.40M |
| Q2 FY1996 | 30 Jun 1996 | 8.29 | 62.20M | 7.50M |
| Q1 FY1996 | 31 Mar 1996 | 10.48 | 78.60M | 7.50M |
| Q4 FY1995 | 31 Dec 1995 | 9.99 | 87.90M | 8.80M |
| Q3 FY1995 | 30 Sept 1995 | 11.24 | 87.70M | 7.80M |
| Q2 FY1995 | 30 Jun 1995 | 10.94 | 95.20M | 8.70M |
| Q1 FY1995 | 31 Mar 1995 | 17.05 | 100.60M | 5.90M |
| Q4 FY1994 | 31 Dec 1994 | 17.82 | 106.90M | 6.00M |
| Q3 FY1994 | 30 Sept 1994 | 13.12 | 97.10M | 7.40M |
| Q2 FY1994 | 30 Jun 1994 | 14.77 | 101.90M | 6.90M |
| Q1 FY1994 | 31 Mar 1994 | 18.89 | 105.80M | 5.60M |
| Q4 FY1993 | 31 Dec 1993 | 7.27 | 53.10M | 7.30M |
| Q3 FY1993 | 30 Sept 1993 | 6.92 | 42.90M | 6.20M |
| Q2 FY1993 | 30 Jun 1993 | 9.50 | 43.70M | 4.60M |
| Q1 FY1993 | 31 Mar 1993 | 8.66 | 40.70M | 4.70M |
| Q4 FY1992 | 31 Dec 1992 | 11.28 | 44.00M | 3.90M |
| Q3 FY1992 | 30 Sept 1992 | 14.63 | 46.80M | 3.20M |
| Q2 FY1992 | 30 Jun 1992 | 16.59 | 48.10M | 2.90M |
| Q1 FY1992 | 31 Mar 1992 | 18.92 | 49.20M | 2.60M |
| Q4 FY1991 | 31 Dec 1991 | 19.15 | 51.70M | 2.70M |
| Q3 FY1991 | 30 Sept 1991 | 11.91 | 27.40M | 2.30M |
| Q2 FY1991 | 30 Jun 1991 | 1.14 | 2.50M | 2.20M |
| Q1 FY1991 | 31 Mar 1991 | — | — | — |
| Q4 FY1990 | 31 Dec 1990 | 2.88 | 4.60M | 1.60M |
| Q3 FY1990 | 30 Sept 1990 | — | — | — |
| Q2 FY1990 | 30 Jun 1990 | — | — | — |
| Q1 FY1990 | 31 Mar 1990 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Debt to equity,All ratios
Common questions about Vertex Pharmaceuticals's current ratio
Source: Financial Modeling Prep